Tirzepatide (Mounjaro): A newer medication that targets multiple pathways for improved weight loss and glucose control
A phase 1 randomized trial found that tirzepatide significantly reduced the amount people ate at a meal compared to a placebo as early as week 3, with participants consuming roughly 520 fewer calories
The mouse monoclonal antibody used was anti-tubulin (#GB13017-2, Servicebio, Wuhan, China, 1:1000)
The Race to Produce Longer-Lasting Drugs Because Byetta had to be injected twice daily, drug companies began searching for longer-lasting GLP-1 medications
Questions worth discussing with your care team include: Which form is more likely to fit my daily routine long-term
Ive always been active and healthy, but I couldnt lose weight